90 filings
Page 3 of 5
8-K
gfk0783kkc6ssf6vvm
20 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
k7cgu15dohp tyiu
10 May 21
Codiak Appoints Jennifer Wheler, M.D., as Chief Medical Officer
5:18pm
8-K
wapg0uvye9dmf59be
6 May 21
Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress
4:10pm
DEFA14A
fx3ribtvd9ytg kmle3
30 Apr 21
Additional proxy soliciting materials
4:26pm
DEF 14A
8c5bpup6fn0 qenxak
30 Apr 21
Definitive proxy
4:23pm
8-K
jxh7ko0z162h98xnhhk
8 Apr 21
Regulation FD Disclosure
4:05pm
8-K
dmvx6 fco87hzhcxh9s
26 Mar 21
Departure of Directors or Certain Officers
4:05pm
S-8
1zx6qkaz
17 Mar 21
Registration of securities for employees
4:41pm
10-K
c96beh9v
17 Mar 21
Annual report
4:15pm
8-K
ez1ei
17 Mar 21
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
7:44am
8-K
dalt3bhcjr7213ml
8 Mar 21
Departure of Directors or Certain Officers
5:18pm
424B4
rraqbm9h
12 Feb 21
Prospectus supplement with pricing info
4:02pm
EFFECT
71etn5 3gs
12 Feb 21
Notice of effectiveness
12:15am
S-1MEF
ynsv58xijxzhtg0m
11 Feb 21
Registration of additional securities for an S-1
9:19pm
CORRESP
n407w9zi 01
9 Feb 21
Correspondence with SEC
12:00am
CORRESP
wsd6gz4nc4jczc
9 Feb 21
Correspondence with SEC
12:00am
8-K
qi7y3pbwws16ohgeahs
4 Feb 21
Codiak Reports Additional Positive Phase 1 Results for exoIL-12™ Confirming
8:46am
8-K
2ka4zu4bej
26 Jan 21
Departure of Directors or Certain Officers
4:39pm